[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@COR2EDMedEd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::719588640171696129.png) @COR2EDMedEd COR2ED

COR2ED posts on X about matterhorn, topics, future of the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::719588640171696129/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::719588640171696129/c:line/m:interactions.svg)

- X Week XXXXXX +86,116%
- X Months XXXXXXX +22%
- X Year XXXXXXX -XX%

### Mentions: X [#](/creator/twitter::719588640171696129/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::719588640171696129/c:line/m:posts_active.svg)

- X Week X +400%
- X Months XX +233%
- X Year XX +7.70%

### Followers: XXXXX [#](/creator/twitter::719588640171696129/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::719588640171696129/c:line/m:followers.svg)

- X Week XXXXX +1.90%
- X Months XXXXX +34%
- X Year XXXXX +42%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::719588640171696129/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::719588640171696129/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::719588640171696129/influence)
---

**Social category influence**
[finance](/list/finance)  [travel destinations](/list/travel-destinations) 

**Social topic influence**
[matterhorn](/topic/matterhorn), [topics](/topic/topics), [future of](/topic/future-of)
### Top Social Posts [#](/creator/twitter::719588640171696129/posts)
---
Top posts by engagements in the last XX hours

"HR+/HER2 metastatic breast cancer can be complex to treat particularly once endocrine resistance develops. In this case-based video Dr Barbara Pistilli discusses the journey of a pretreated patient with HR+/HER2 (IHC 0) mBC who developed endocrine resistance. She explores: ADCs as effective manageable alternatives to ChT Mechanism of action & available options Strategies for managing AEs Watch the case study on YouTube here: #BreastCancer #MedEd #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca"  
[X Link](https://x.com/COR2EDMedEd/status/1980626651860898173) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-21T13:26Z 1004 followers, XX engagements


"Just released Gastric & gastroesophageal cancer update from ESMO25 📺 Dr @LizzySmyth1 shares her gastric & GE cancer highlights & reviews the latest data from MATTERHORN trial This independent programme is supported by COR2ED"  
[X Link](https://x.com/COR2EDMedEd/status/1980936719882166537) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-22T09:58Z 1004 followers, 45K engagements


"📢Just released Gastric & #gastroesophageal cancer update from #ESMO25 📺 Dr @LizzySmyth1 shares her #gastric & GE cancer highlights & reviews the latest data from #MATTERHORN trial See more updates from #ESMO This independent programme is supported by COR2ED #MedEd #GastricCancer #GIcancer"  
[X Link](https://x.com/COR2EDMedEd/status/1979915435643396568) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-19T14:19Z XXX followers, XXX engagements


"Join the discussion Experts will review the latest data on gastric & gastroesophageal cancer from ESMO25 in a virtual Experts Knowledge Share What will new data mean for clinical practice 19th November 17:00 -18:15 CET / 11:00 -12:15 EST Topics: -Future of targeted therapy & IO -Peri-operative approaches -Developments in ESCC -Panel discussion/Q&A Meeting Chair: Dr @LizzySmyth1 (UK) Co-Chairs: Prof. Aziz Zaanan (France) & Prof. Markus Moehler (Germany) Endorsed by: @dice_europe This independent programme is supported by an educational grant from Amgen"  
[X Link](https://x.com/COR2EDMedEd/status/1981387163431252254) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-23T15:48Z XXX followers, XX engagements